Two new biopharma companies pursuing very different business models have raised nearly $50 million, with San Francisco venture firm venBio leading both Series A rounds.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?